Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?

Registro completo de metadados
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorPinke, Karen Henriette-
Autor(es): dc.creatorZorzella-Pezavento, Sofia Fernanda Gonçalves-
Autor(es): dc.creatorde Campos Fraga-Silva, Thais Fernanda-
Autor(es): dc.creatorMimura, Luiza Ayumi Nishiyama-
Autor(es): dc.creatorde Oliveira, Larissa Ragozo Cardoso-
Autor(es): dc.creatorIshikawa, Larissa Lumi Watanabe-
Autor(es): dc.creatorFernandes, Ana Angélica Henrique-
Autor(es): dc.creatorLara, Vanessa Soares-
Autor(es): dc.creatorSartori, Alexandrina-
Data de aceite:
Data de disponibilização:
Data de envio:
Data de envio:
Data de envio:
Fonte completa do material: dc.identifier
Fonte completa do material: dc.identifier
Fonte: dc.identifier.uri
Descrição: dc.descriptionMultiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by extensive inflammation, demyelination, axonal loss and gliosis. Evidence indicates that mast cells contribute to immunopathogenesis of both MS and experimental autoimmune encephalomyelitis (EAE), which is the most employed animal model to study this disease. Considering the inflammatory potential of mast cells, their presence at the CNS and their stabilization by certain drugs, we investigated the effect of ketotifen fumarate (Ket) on EAE development. EAE was induced in C57BL/6 mice by immunization with MOG35-55 and the animals were injected daily with Ket from the seventh to the 17th day after disease induction. This early intervention with Ket significantly reduced disease prevalence and severity. The protective effect was concomitant with less NLRP3 inflammasome activation, rebalanced oxidative stress and also reduced T cell infiltration at the CNS. Even though Ket administration did not alter mast cell percentage at the CNS, it decreased the local CPA3 and CMA1 mRNA expression that are enzymes typically produced by these cells. Evaluation of the CNS-barrier permeability indicated that Ket clearly restored the permeability levels of this barrier. Ket also triggered an evident lymphadenomegaly due to accumulation of T cells that produced higher levels of encephalitogenic cytokines in response to in vitro stimulation with MOG. Altogether these findings reinforce the concept that mast cells are particularly relevant in MS immunopathogenesis and that Ket, a known stabilizer of their activity, has the potential to be used in MS control.-
Idioma: dc.languageen-
Relação: dc.relationNeurotherapeutics-
Direitos: dc.rightsopenAccess-
Palavras-chave: dc.subjectBlood-CNS barrier-
Palavras-chave: dc.subjectExperimental autoimmune encephalomyelitis-
Palavras-chave: dc.subjectInflammasome-
Palavras-chave: dc.subjectKetotifen fumarate-
Palavras-chave: dc.subjectMultiple sclerosis-
Palavras-chave: dc.subjectOxidative stress-
Título: dc.titleCalming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.